Nadine Leonie de Boer
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 05, 2024
The importance of integrating diagnostic modalities in patient selection for CRS-HIPEC in colorectal peritoneal metastases.Nadine L de Boer, Checca Bakkers, Alexandra Rm Brandt-Kerkhof
|Jul 19, 2023
Phase I study of intraperitoneal irinotecan combined with palliative systemic chemotherapy in patients with colorectal peritoneal metastases.Ruben A G van Eerden, Nadine L de Boer, Job P van Kooten
|Jul 03, 2020
A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer.Nadine L de Boer, Koen Rovers, Jacobus W A Burger
|Dec 11, 2019
Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial.Nadine Leonie de Boer, Alexandra R M Brandt-Kerkhof, Eva V E Madsen
|May 17, 2019
Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.Nadine L de Boer, Job P van Kooten, Jacobus W A Burger
Pageof 1
